THE TAPE
COO · Ophthalmic Goods · $11.8B

The Cooper Companies, Inc. Common Stock

$61.88▼ −1.23%
Last close
Relative strength
24RS
of 99, against every stock▲ +7 on the month
Turning up
Unconfirmed
+1.4%
six months against the S&P 500
52-week range
−31.1%
from the high
$51.01$89.83
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
16 days
Dec 2 · confirmed
Growth FLATProof SHOWN
Quarter to Jul 31, revenue +1% on a year ago
Why it is on no screen

COO is off the screens on one check: relative strength.

A base has formed19.4 weeks, from 61.77 to 77.06.
Long enough to count19.4 weeks against 3 needed.
Shallow enough19.8% deep against 35% allowed.
Close to its pivot-19.7% from the pivot; listed down to -20%.
Relative strengthRS 24 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$54.08
-12.6% · tested 4× · last 23 sessions ago
Resistance above
$65.51
+5.9% · tested 3× · last 7 sessions ago

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The Cooper Companies, Inc. Common Stock is not on any of the screens right now. Its relative strength rating is 24, and it sits in Ophthalmic Goods.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+10.2%
Three months against the S&P 500
-15.3%
Six months against the S&P 500
+1.4%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same theme
No themes — common and fine.
Catalyst roadmap
16
days
Earnings in 16 days
Dec 2, 2026
  1. Earningsconfirmedin 16d
    Quarterly earnings
    Dec 2, 2026
How it moves on earnings

On average 10.7% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$4.2B
+0.6% year on year
Operating margin
12.8%
gross 65.9%
Net margin
13.5%
Free cash flow
$678.0M
5.8% of market cap
Price to sales
2.78×
Price to earnings
20.6×

Twelve months to Jul 31, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$1.1B
-1.4% QoQ · +0.6% YoY
Gross margin
66.8%
-1.2 pts QoQ
Net income
$432.8M
Positive
Free cash flow
$273.0M
Cash generating

What the numbers say

  • Revenue +0.6% year over year, -1.4% on the quarter
  • Weak: Gross margin 66.8%, -1.2 points on the quarter
  • Good: Profitable: net income $433M, operating margin 20.8%
  • Good: Cash generating: operating cash flow $342M, free cash flow $273M
  • Good: Share count -3.3% in a year: buying back
  • Weak: Net debt $2.39B · cash $155M
Revenue by quarter
Free cash flow
Net income
shares -3.3% in a year · net debt $2.4B
Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is gross margin: gross margin 66.8%, -1.2 points on the quarter.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

Held by 3 of 46 tracked funds at the end of Q3 2026.

Last quarter: 3 added.

Checking your subscription…

From 13F filings, which show long stock only and arrive up to 45 days after the quarter. The broad quant funds are left out.

Flagged by the market sweep
Pulled back while its group leadsTape · 2026-11-13
3 lower closes in a leading group, 50d held, at 62.19
Mixed: stocks have lagged random stocks by 1.0% over three sessions, not consistently enough to call (433 cases over 59 nights). Against their own sector they have lagged by 0.9%.
GappedTape · 2026-11-05
+5.9%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
A director or officer changedFiling · 2026-10-28
5.02
No measurable effect: stocks behave like random ones over the next three sessions (1,288 cases over 54 nights).
Several insiders boughtInsider · 2026-10-15
3 insiders, $1,880,110 in 30d
No measurable effect: stocks behave like random ones over the next three sessions (269 cases over 58 nights).
Several insiders boughtInsider · 2026-10-14
3 insiders, $1,880,110 in 30d
No measurable effect: stocks behave like random ones over the next three sessions (269 cases over 58 nights).
Several insiders boughtInsider · 2026-10-13
3 insiders, $1,880,110 in 30d
No measurable effect: stocks behave like random ones over the next three sessions (269 cases over 58 nights).
Several insiders boughtInsider · 2026-10-12
3 insiders, $1,880,110 in 30d
No measurable effect: stocks behave like random ones over the next three sessions (269 cases over 58 nights).
Several insiders boughtInsider · 2026-10-09
3 insiders, $1,880,110 in 30d
No measurable effect: stocks behave like random ones over the next three sessions (269 cases over 58 nights).

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What analysts expect
Strong buy3
Buy3
Hold11
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
The Cooper Companies, Inc. Common Stock (COO) — The Tape